AI-backed clinical compliance company Brellium has landed $16.7 million in Series A funding.

First Round Capital and Left Lane Capital led the latest funding round.

The New York-based software company specializes in providing compliance tools for applied behavior analysis (ABA) services, behavioral health care, substance use disorder centers and allied health services, such as speech, occupational therapy and speech therapy. Additionally, it offers tools to a number of physical health providers. 

Its clients include a number of autism providers, including Hopebridge, Thrive ABA Therapy Services, Action Behavior Centers, Brighter Strides and Compass ABA.

Founded in 2021, Brellium specializes in documentation and regulatory compliance, as well as organizational intelligence.

This isn’t the only company supporting autism providers that has recently landed significant investor attention.

ABA software startup Motivity raised $27 million last month in a round led by Five Elms Capital. The Hawaii-based company said the new capital would be used to expand its team and accelerate product development. 

Dealmaking in the autism software space has also seen some action recently.

In March, CentralReach, an ABA software company, sold to Roper Technologies Inc. (Nasdaq: ROP) for $1.65 billion. 

Autism services software has previously caught the attention of big names in the industry. For example, in 2023, CVS Health Ventures led SpectrumAi’s $20 million Series A funding round.